Evidence map›Paper›PMID 38414693›Full record

ReviewCureus2024

Critical Challenges and Frontiers in Cartilage Tissue Engineering.

Madhan Jeyaraman, Naveen Jeyaraman, Arulkumar Nallakumarasamy, Swaminathan Ramasubramanian, Sankalp Yadav

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Co-Culture Approaches in Cartilage and Bone Tissue Regeneration.International journal of molecular sciences · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Madhan JeyaramanOrthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai, IND.
Naveen JeyaramanOrthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai, IND.
Arulkumar NallakumarasamyOrthopaedics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Karaikal, IND.
Swaminathan RamasubramanianOrthopaedics, Government Medical College, Omandurar Government Estate, Chennai, IND.
Sankalp YadavMedicine, Shri Madan Lal Khurana Chest Clinic, New Delhi, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cartilage tissue engineering has witnessed considerable advancements since its establishment in 1977, evolving from rudimentary surgical interventions to more nuanced biotechnological approaches. The field has navigated various challenges encompassing cellular considerations, scaffold material selection, environmental factors, and ethical and regulatory constraints. Innovations in cell source diversification, including chondrocytes, mesenchymal stem cells, and induced pluripotent stem cells, have been instrumental but not without their limitations, such as restricted cell proliferation and ethical dilemmas. Scaffold materials offer a unique dichotomy between natural substrates, which provide biocompatibility, and synthetic matrices, which grant mechanical integrity. However, translational hurdles in clinical applicability persist. Environmental factors, such as growth factors and thermal and mechanical forces, have been recognized as influential variables in cellular behavior and tissue maturation. Despite these strides, integration with host tissue remains a significant challenge, involving mechanical and immunological complexities. Looking forward, emerging technologies such as 3D and 4D printing, nanotechnology, and molecular therapies hold the promise of refining scaffold design and enhancing tissue regeneration. As the field continues to mature, a multidisciplinary approach encompassing thorough scientific investigation and collaboration is indispensable for overcoming existing challenges and realizing its full clinical potential.

Indexed as

3d printingcartilage tissue engineeringchondrocytesmolecular therapiesnanotechnology

Identifiers

PMID38414693
PMCPMC10897756

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.